Table 3 Allogeneic bone-forming cell implantation procedure (safety population)
Procedure characteristics | Â |
|---|---|
Total number of participants | 22 |
Time from fracture to implant (months) | Â |
 Mean (SD) | 6.59 (1.159) |
 Median (min–max) | 6.9 (3.9–7.9) |
Prescribed dose | Â |
 2 ml | 8 (36.4) |
 3 ml | 1 (4.5) |
 4 ml | 13 (59.1) |
Allogeneic bone-forming cell implantation using two different surgical approaches, n (%)* | |
 No | 11 (78.6) |
 Yes | 3 (21.4) |
Type of anaesthesia, n (%) | Â |
 General | 20 (90.9) |
 Loco-regional | 2 (9.1) |
Length of stay at the hospital (days), mean (SD) | 1.68 (0.78) |